MRM are no doubt doing their year end, should be interesting discussions... I expect an impairment on assets as pre previous posts. Fingers crossed re the banks.
At this time no new info from NYSE industry competitors. About a month away.
None the less my hunches are an investment in MRM might work out if:
- you have at least a 2019 or 2020 horizon
- you are prepared to spend a bit of capital to help MRM between now and then. 30 cents a share injection from all holders would knock off over $100m of debt and with a few asset sales you might just make it to 2019 or 2020 and it could be a nice investment then.
MRM Price at posting:
30.5¢ Sentiment: Sell Disclosure: Held